key: cord-0775486-7jdjvhqm
authors: Ma, Yuanwu; Lu, Dan; Bao, Linlin; Qu, Yajin; Liu, Jiangning; Qi, Xiaolong; Yu, Lei; Zhang, Xu; Qi, Feifei; Lv, Qi; Liu, Yunpeng; Shi, Xudong; Sun, Caixian; Li, Jing; Wang, Jie; Han, Yunlin; Gao, Kai; Dong, Wei; Liu, Ning; Gao, Shan; Xue, Jing; Wei, Qiang; Pan, Sidan; Gao, Hong; Zhang, Lianfeng; Qin, Chuan
title: SARS‐CoV‐2 infection aggravates chronic comorbidities of cardiovascular diseases and diabetes in mice
date: 2021-03-06
journal: Animal Model Exp Med
DOI: 10.1002/ame2.12155
sha: 1e617e4e2ec6db9f269663832e501b2f5307eb70
doc_id: 775486
cord_uid: 7jdjvhqm

BACKGROUND: Cardiovascular diseases (CVDs) and diabetes mellitus (DM) are top two chronic comorbidities that increase the severity and mortality of COVID‐19. However, how SARS‐CoV‐2 alters the progression of chronic diseases remain unclear. METHODS: We used adenovirus to deliver h‐ACE2 to lung to enable SARS‐CoV‐2 infection in mice. SARS‐CoV‐2’s impacts on pathogenesis of chronic diseases were studied through histopathological, virologic and molecular biology analysis. RESULTS: Pre‐existing CVDs resulted in viral invasion, ROS elevation and activation of apoptosis pathways contribute myocardial injury during SARS‐CoV‐2 infection. Viral infection increased fasting blood glucose and reduced insulin response in DM model. Bone mineral density decreased shortly after infection, which associated with impaired PI3K/AKT/mTOR signaling. CONCLUSION: We established mouse models mimicked the complex pathological symptoms of COVID‐19 patients with chronic diseases. Pre‐existing diseases could impair the inflammatory responses to SARS‐CoV‐2 infection, which further aggravated the pre‐existing diseases. This work provided valuable information to better understand the interplay between the primary diseases and SARS‐CoV‐2 infection.

COVID-19 patients, CVDs and DM are associated with 22.7% and 19.7% mortality rates, respectively. These numbers are higher than the mortality without comorbidities. 2 A similar observation was also reported in severe acute respiratory syndrome (SARS) epidemic in 2002/2003. 5 Therefore, understanding the mutual influences between comorbidities and COVID-19 is critical for the development of better strategies to control and treat these diseases.

Human angiotensin-converting enzyme 2 (hACE2) is the receptor of SARS-CoV-2 that interacts with the spike (S) protein and mediates viral entry into the cells. 6 Although the murine ortholog of ACE2 (mACE2) presents over 81% similarity with hACE2, mACE2 is not capable to mediate SARS-CoV-2 infection. Therefore, ectopic expression of hACE2 is necessary for SARS-CoV-2 to infect murine cells. [6] [7] [8] [9] Several hACE2 transgenic mice has been developed to study the infection mechanisms and pathogenicity of SARS-CoV-2. [7] [8] [9] Although these mice can be bred with other murine disease models to investigate the interactions between comorbidities and COVID-19, this strategy is slow and expensive. Alternatively, several groups recently established adenovirus-based hACE2 delivery systems to murine lungs, and built a quick and convenient approach to sensitize the mice for SARS-CoV-2 infection and COVID-19 pathogenesis. 10, 11 Here we optimized a virus-based approach to deliver hACE2 to murine models of CVDs and DM, and investigated the mutual impacts between these preexisting diseases and SARS-CoV-2 infection. We found that preexisting CVDs and DM aggravated the pathological phenotypes of pneumonia and impairment of the immune response due to SARS-CoV-2 infection. Underlying CVDs increased the risk of SARS-CoV-2 virus particle invasion in myocardium. SARS-CoV-2 infection aggravated myocardial defeats in CVD models, and accumulated oxidative stress and activated apoptosis pathway induced by inflammation contribute to myocardial injury.

In diabetic mice, SARS-CoV-2 infection resulted in increased blood glucose and abnormal glucose tolerance, and significantly decreased bone mineral density (BMD). Taken together, our comorbid mouse models mimicked the complex pathological symptoms of COVID-19 patients with preexisting cardiovascular disease or diabetes. They both showed impairments of immune response during SARS-CoV-2 infection, which result in damage to disease-related target organs.

Our results provided valuable information for better understanding of mutual impacts between these preexisting chronic diseases and COVID-19.

Specific pathogen-free, 6-to 10-week male C57BL/6, BABL/c, and ob/ob mice were purchased from Beijing HFK BIOSCIENCE CO., LTD. 

Mice were anesthetized with isoflurane and intranasally administered with 2.5 × 10 8 Ad5-hACE2 or Ad5-Empty in 50 μL DMEM. To detect hACE2 expression after Ad5-hACE2 transduction, C57BL/6 mice lungs were collected at day 0, 3, 5, 7, 10, 15, 20, and 30. The human ACE2 expression was detected using western blot and realtime PCR.

Five to seven days post-Ad5-hACE transduction, mice were intranasally infected with SARS-CoV-2 stock virus at a dosage of 10 5 TCID 50 or PBS as mock infection control. The viral copies in mice lung or other tissues were using the methods described before. 7 

Total RNA was isolated from tissues using TRIzol Reagent (15596018, Thermo Fisher). The cDNA was synthesized using total RNA follow the instruction of Superscript III reverse transcriptase manufacturer's protocol (RR047A, TaKaRa). Primers used for real-time PCR detection are listed in Table S1 .

Total protein lysates of different tissues were obtain as described before. 22 We use SDS-PAGE to separate the protein and use target antibody to detect the express in nitrocellulose membranes. Antibody including anti human ACE2 antibody (1:250 dilution, MAB933, R&D) and cTnI antibody (1:1000 dilution, ab47003, Abcam).

Major organs were grossly examined in the ABSL3 laboratory and then fixed in 10% buffered formalin solution and then paraffin sections (3-4 μm) were prepared. Hematoxylin and eosin (H&E) staining and modified Masson's Trichrome staining were performed to determine the histopathologic changes as described before. 7, 12, 17 Paraffin sections of lungs or hearts were used for the expressional distribution of several proteins. Briefly, sections were dewaxed and rehydrated, and heat-induced antigen retrieval routinely. Then the sections were blocked and incubated with appropriate primary and secondary antibodies. Antibody to hACE2 (1:50 dilution, MAB933, R&D Systems), rabbit polyclonal antibody to SARS-Cov-2 Spike antibody (1:100 dilution, 21804, SIgnalway), CD4 (1:1000 dilution, ab183685, Abcam), CD8 (1:2000 dilution, ab217344, Abcam), and Mac (1:1000 dilution, Cl8942AP, Cedarlane) were used as the primary antibody. For immunohistochemical analysis, a secondary kit (Beijing ZSGB Biotechnology) were used, followed determination using an Olympus microscope. For immunofluorescence analysis of SARS-CoV-2 antigen, a secondary antibody conjugated with FITC (goat anti-rabbit, A11008, Invitrogen) and TRITC (goat anti-mouse, A21424, Invitrogen) were used, followed by fluorescence microscopy. For hexamine silver staining, briefly, sections of hearts were in turn treated with periodic acid, hexamine silver, gold chloride, and sodium thiosulfate, and finally stained with nuclear solid red, followed determination via a Olympus microscope.

Major organs were grossly examined in the ABSL3 laboratory, fixed in 10% buffered formalin solution, and then paraffin sections 

The N-Terminal Pro Brain Natriuretic Peptide (NT-proBNP) in peripheral blood was determined using an enzyme-linked immunosorbent assay (ELISA) kit (orb441265, Biorbyt). Briefly, 96-well plates in the kit were precoated with the target antibody; the tested serum was diluted with the diluent provided in the kit (1:5), added into the appropriate wells, and then incubated for 2 hours at 37℃. After the incubation with the secondary antibody for 1 hr at 37℃, plates were washed five times with wash solution. The reaction was developed by TMB substrate reagent and then stopped after 15 minutes by adding the stop solution provided by the kit. Plates were then read at a wavelength of 450 nm.

For blood glucose and biochemistry analysis, the ob/ob mice were deprived from food except free accesses to water for 16 hours (21:00 pm to 9:00 am). The fasted blood glucose was measured from tail blood by an ONETOUCH UltraEasy glucometer (Johnson, US).

Insulin tolerance test (ITT) was performed as previously described. 35 Briefly, ob/ob mice were fasted for 4 hours (9:00 am-13:00 pm). Blood samples were collected from tail for determination of baseline values of blood glucose (t = 0). The mice were then intraperitoneal injected with human insulin 1 U/kg, and then blood glucose was measured at 15, 30, 60, 90, and 120 minutes after insulin injection. The values of area under the glucose-time curve (AUC) were calculated.

For serum biochemistry, the fasted serum was collected from vein after the measurement of fasted blood glucose. The levels of TG, TC, LDL, HDL, r-GT, ALP, AST, and ALT were measured using a TBA2000FR biochemical analyzer (TOSHIBA, Japan).

The mice lower limbs (femur and tibia) were dissected and collected for the micro-CT measurements. The femurs of the mice were scanned 

All data were analyzed with GraphPad Prism 8.0 software. Comparisons between two groups were made by unpaired two-tailed Student's t tests. All values are expressed as mean ± s.e.m. *P < .05, **P < .01, ***P < .001 for two-tailed Student's t tests, unless stated otherwise.

To establish a robust hACE2 delivery system targeting murine lungs, we first intranasally treated 6-to 10-week-old C57BL/6 mice with three different viral vectors and compared their efficiency in gene delivery. The dosages and vectors included 2.5 × 10 8 TU lentivirus (lenti-hACE2), 2.5 × 10 8 PFU replication-deficient adenovirus (Ad5-hACE2), and 1.0 × 10 12 vg/mL adeno-associated virus (AAV6-hACE2). At 0, 3, 5, 7, and 10 days after transduction (d.a.t.), we performed real-time PCR to measure hACE2 expression in murine lungs. We found adenoviral vectors established faster and higher hACE2 expression as compared to the other methods. (Figure S1A ,B).

Next, we focused on the Ad5-hACE2 approach and explored the dynamics of exogenous hACE2 expression. We determined hACE2 expression in the lungs at 3, 5, 7, 10, 15, 20, and 30 d.a.t. by real-time PCR and western blot ( Figure S1C -E, n = 3 at each time point). Two ACE2 antibodies were used in western blot, one recognizing both mACE2 and hACE2 ( Figure S1D ), and the other specifically probing hACE2 ( Figure S1E ). This experiment showed the ectopic hACE2 expression peaked between 5 and 7 d.a.t.

We further increased the dose of Ad5-hACE2 and re-administered the virus to the same animals. However, these experiments did not further enhance hACE2 expression levels ( Figure S1F ,G). The immunohistochemistry analysis showed that hACE2 was predominantly expressed in the alveolar epithelium ( Figure S1H ). After optimization of the hACE2 transduction strategy, we successfully infected wildtype (WT) C57BL/6 mice with 10 5 TICD 50 of SARS-CoV-2 or mock virus ( Figure S1I ). Together, we have established the approach that permits SARS-CoV-2 research in disease mouse models.

We used two CVD and one DM mouse models to study the impacts of preexisting disease on SARS-CoV-2 infection and pneumoniarelated phenotypes.

In the first CVD model, we treated mice with adriamycin (ADR), a well-established chemical that induced stress and injury in the myocardium. [12] [13] [14] Before Ad5-hACE2 transduction, all ADR administered mice displayed typical cardiac damages that were characterized by enlarged cardiac chambers, reduced ventricular wall thickness, and significantly decreased cardiac functions as detected by echocardiography 12-15 ( Figure S2A -G). The ADR-treated mice were first inoculated intranasally with Ad5-hACE2 at day 14 after cessation of ADR treatment and then infected with SARS-CoV-2 (day 19) five days after Ad5-hACE2 inoculation ( Figure 1A) . The second CVD model in this study was cTnT R141W transgenic mice, which displayed typ- We quantified viral RNA by real-time PCR using lung tissues. We found that the viral RNA copies were 10 7.04 , 10 8.01 , 10 7.69 , and 10 7.13 copies/mL, respectively, in four SARS-CoV-2 groups ( Figure 1E , n = 4 in WT-mock and WT-SARS-CoV-2 groups; n = 5 in ADR-mock group and n = 10 in ADR-SARS-CoV-2 group; n = 3 in cTnT R141W -mock group and n = 5 in cTnT R141W -SARS-CoV-2 group; n = 12 in ob/ob-mock and ob/ob-SARS-CoV-2 groups). However, no statistically significant of viral RNA loads between these four SARS-CoV-2 groups.

In addition, we performed immunofluorescence to detect the colocalization of SARS-Cov-2 S protein and hACE2 receptor in alveolar epithelial cells in lung tissues from SARS-CoV-2 and mock groups ( Figure 1F , and Figure S5 ). Meanwhile, the virus infection was further confirmed by in situ hybrization (ISH) in lung tissues ( Figure 1G,H) .

In the WT-SARS-CoV-2 group, the damaged lungs became swollen and enlarged as compared to the WT-mock mice, which showed homogeneously pink and slightly deflated lung lobes, by gross and histopathologic analyses ( Figure 1G ). The WT-SARS-CoV-2 group also showed multifocal lesions with coalescent scattered-dark reddishpurple areas and focal palpable nodules throughout the lung lobes.

Microscopically, the lung tissues from WT-SARS-CoV-2 mice displayed moderate interstitial pneumonia, which was characterized by the infiltration and accumulation of inflammatory cells and thickened alveolar septa throughout the right robe of the lung. In addition, perivasculitis and peribronchitis were observed in the lung of WT-SARS-CoV-2 group ( Figure 1G ,I,J). Compared with WT-SARS-CoV-2 mice, damaged lungs in CVD and DM mice became more swollen and enlarged, with multifocal scattered-dark reddish-purple areas throughout the lung lobes. Microscopically, comorbid mice displayed more severe pneumonia phenotypes, including infiltration of inflammatory cells, thickened alveolar septa, and perivasculitis (Figure 1 ,J). -SARS-CoV-2 group, n = 5 in ob/ob-mock and ob/ob-SARS-CoV-2 group). We also detected the inflammatory factors production cells aggregation, such as macrophage cells ( Figure 2G ). Recent study indicated that the IFN production contributed to viral RNA clearance and related to the severity of COVID-19 in patients. 18, 19 In our comorbid mouse models, the production of pro-inflammatory factors IL-6, TNFα, and IFNγ was impaired in CVD and DM models with SARS-CoV-2 infection. This may indicate that the impairment of immune response and reduction of viral RNA clearance result in bad histopathologic changes in comorbid mouse models. The impairment of anti-inflammatory factor IL-10 production was also observed in DM model, but not in CVD models ( Figure 2B,E) . Furthermore, we tested 

We then examined the impact of SARS-CoV-2 infection on the heart of CVD comorbidities. The heart weight in the WT-SARS-CoV-2 and cTnT R141W -SARS-CoV-2 groups was slightly higher than that of their respective mock groups, but given no significance, and SARS-CoV-2 infection resulted in decrease in heart weight in the ADR-SARS- Cardiomyocyte hypertrophy and myofibril disarray were observed in WT-SARS-CoV-2 mice, and these phenotypes appeared more severe in CVD comorbid mice. ADR-SARS-CoV-2 mice exhibited thin wall, reduced heart weight, myocardial damage, and increased cardiac fibrosis, while cTnT R141W -SARS-CoV-2 mice exhibited thin wall, larger chamber, heavier heart weight, myocyte malalignment, and increased collagen deposition as demonstrated using H&E F I G U R E 1 Preexisting CVDs and DM exacerbates the histopathologic changes in pneumonia during SARS-CoV-2 infection. Schematic diagram of study strategy on ADR-induced myocardial injury comorbid mice model (A), cTnT R141W familial dilated cardiomyopathy (FDCM) comorbid mice model, and ob/ob diabetic comorbid mice model (B). Weight changes (C and D) were monitored daily after received SARS-CoV-2, and virus load (E) at 5 d post-SARS-CoV-2 or mock intranasally (n = 4 in WT-mock and WT-SARS-CoV-2 groups, n = 5 in ADR-mock and n = 10 in ADR-SARS-CoV-2 groups, n = 3 in cTnT R141W -mock and n = 5 in cTnT R141W -SARS-CoV-2 groups; n = 12 in ob/ob-mock and ob/ob -SARS-CoV-2 groups). The co-localization of SARS-CoV-2 S protein and hACE2 receptor (F) was detected by immunofluorescence (anti-SARS-CoV-2 S protein antibody (green), anti-human ACE2 antibody (red) and DAPI (blue), n = 3 per group, white bar = 100 μm). Viral RNA was detected using ISH in lung tissues (G-H). Postmortem examination showed multifocally scattered-dark reddish purple areas and palpable nodules from lung at 5dpi (G), and histopathologic observation indicated that moderate interstitial pneumonia with infiltration of lymphocytes (yellow arrow) and thickened alveolar septa (blue arrow), and serious perivasculitis (red arrow) and peribronchitis (green arrow) were also shown in SARS-CoV-2 groups (I-J, n = 3 per group, black bar = 400 μm, red bar = 100 μm) F I G U R E 2 Comorbid mice showed impaired innate immune responses during SARS-CoV-2 infection. A-F, The mRNA level of IL-6, IL-10, and TNFα in WT-mock, WT-SARS-CoV-2, ADR-mock, ADR-SARS-CoV-2, cTnT R141W -mock, and cTnT R141W -SARS-CoV-2 groups or in WTmock, WT-SARS-CoV-2, ob/ob-mock, and ob/ob-SARS-CoV-2 groups. G, Immunohistochemistry analysis of CD4, CD8, and Mac cells in all the comorbid mice models. H-O, Protein expression of p-JAK1/2, p-Stat1 and IFNγ were detected in six CVD comorbid groups and four DM comorbid groups by western blot. *P < .05, **P < .01, ***P < .001 and ****P < .001 vs respective mock groups, n = 3 per group F I G U R E 3 SARS-CoV-2 infection aggravated myocardial injury in cardiovascular comorbid mice. A, Heart weight at 5 dpi (*P < .05 vs ADR-mock group). B, Viral RNA detected by real-time PCR, about 10 4.27 copies/mL, in myocardium of 2/10 (20%) mice from ADR-SARS-CoV-2 group, about 10 4.12 copies/mL, in myocardium of 2/5 (40%) mice from cTnT R141W -SARS-CoV-2 group at 5 dpi (n = 5 in ADR-mock and n = 10 in ADR-SARS-CoV-2 groups, n = 3 in cTnT R141W -mock and n = 5 in cTnT R141W -SARS-CoV-2 groups). C, The localization of SARS-CoV-2 S protein and hACE2 receptor detected by immunofluorescence in heart tissues, and the sections were incubated with anti-SARS-CoV-2 S protein antibody (green), anti-human ACE2 antibody (red), and DAPI (blue). SARS-CoV-2 S protein was demonstrated in myocardium in SARS-CoV-2 group (white arrow, n = 3 per group, white bar = 100 μm). D, NT-proBNP was detected in peripheral blood by Elisa at 5dpi (n = 4 in WT-mock and WT-SARS-CoV-2 groups, n = 5 in ADR-mock and n = 10 in ADR-SARS-CoV-2 groups, n = 3 in cTnT R141W -mock and n = 5 in cTnT R141W -SARS-CoV-2 groups). E-G, cTnI was detected by western blot (n = 4 per group) in myocardium at 5 dpi (*P < .05, **P < .01, ****P < .0001 vs respective mock group). H&E staining of the whole-heart transverse sections (H, black bar = 2 mm), and magnification of H&E (I), Masson trichrome-stained (J) and silver staining (K) in myocardium section at 5 dpi (white bar = 50 μm) staining and mason trichrome staining ( Figure 3H-J) . Furthermore, it exhibited more severe nerve fibers break and entangle in CVD comorbid mice by argentation ( Figure 3K ).

Next, we analyze the possible mechanisms that cause myocardial damage. Inflammatory activation and cytokine release could lead to oxidative stress, and we found that SOD1, SOD2, and iNOS increased more in our two CVD comorbid mice groups than in the WT group when compared with respective mock groups ( Figure 4C , n = 3 per group), which indicated the accumulation of oxidative stress products. Meanwhile, we found that GPX1 and GST levels decreased in our CVD comorbid mice group than in the WT mice group when compared with their respective mock groups ( Figure 4D ,E, n = 3 per group), which indicated that the decrease in the scavenging ability of oxidative stress products.

Then, we found that disrupted ultrastructure, including swollen mitochondria with loss of cristae and vacuolization, poorly organized myofibrils with diffusion, damage, and lysis were more severe in CVD comorbid mice after SARS-CoV-2 infection as observed using transmission electron microscopy (TEM) ( Figure 4F ).

We then detected the expression of marker proteins of mitochondrial complex I, II and III, and key enzyme in tricarboxylic acid cycle using western blot. We also found that NDUFS3 (core subunit of complex I), NUBPL (core subunit of complex I), SDHB (involved in electron transport in the complex II), UQCRC2 (core subunit of complex III), and ACO2 (aconitase 2, participates in ATP generation) decreased significantly in our two CVD comorbid mice groups than in the WT group when compared with respective mock groups ( Figure 4G -L, n = 3 per group).

The structure and function of mitochondria are obviously damaged, which could further lead to a caspase cascade. We found that Fas was increased significantly and caspases 8, 9, and 3 were activated in our two CVD comorbid mice group than in the WT group when compared with their respective mock groups ( Figure 4G ,M-P, n = 3 per group).

Our result suggested that oxidative stress induced by the inflammatory response further damaged the structure and function of mitochondria. Therefore, the mitochondria-dependent apoptotic pathway was activated and induced myocardial apoptosis, which together with the abnormally increased inflammatory response in myocardium led to myocardial injury ( Figure 4O ).

During SARS-CoV-2 infection, we found that fast blood glucose increased in the WT-SARS-CoV-2 group when compared with the WT-mock group, but given no significance, and this index increased remarkably in our comorbid diabetic mice ( Figure 5A , P = .0728, WT-SARS-CoV-2 vs WT-mock group; P = .0198, ob/ob-SARS-CoV-2 vs ob/ob-mock group; n = 4 in WT-mock and WT-SARS-CoV-2 group, n = 6 in ob/ob-mock and ob/ob-SARS-CoV-2 group). We also observed decreased insulin tolerance test (ITT) response ( Figure 5B-C) .

As we know, the biochemical parameters, such as triglyceride (TG), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and total cholesterol (TC) are significantly higher in ob/ob mice than in WT mice. 20 Here, we performed the biochemical analysis during SARS-CoV-2 infection. Our data showed decreased in TG ( Figure 5D 

Patients with chronic diseases, such as CVDs and DM, exhibited increased risks in viral infection-related diseases. 21 CVDs and DM are the top two comorbidities that increase the severity and mortality of the COVID-19. 1-4 Therefore, it is an urgent need to understand F I G U R E 4 Mitochondrial injury and oxidative stress and apoptosis of cardiomyocytes contribute to myocardial injury in CVD comorbid mice. A-E, The mRNA level of SOD1, SOD2, iNOS, GPX1, and GST in WT-mock, WT-SARS-CoV-2, ADR-mock, ADR-SARS-CoV-2, cTnT R141Wmock, and cTnT R141W -SARS-CoV-2 groups. (F) Damaged mitochondria were observed through transmission electron microscopy (TEM) in myocardium from six groups (red star indicated mitochondria and green arrow indicated myocardial fibrosis). Protein expression of NDUFS3, NUBPL, SDHB, UQCRC2, ACO2, pro-caspase-8, activated caspase-8, pro-caspase-9, activated caspase-9, pro-caspase-3, and activated caspase-3 were detected by western blot (G-P). *P < .05, **P < .01, ***P < .001 vs respective mock groups, n = 3 per group. Schematic diagram for pathogenic mechanism of myocardial damage in CVD comorbid mice (Q) F I G U R E 5 SARS-CoV-2 infection aggravated blood glucose control and bone metabolism in diabetes diseases mice. A, Fast blood glucose at 5 dpi (*P < .05 vs ob/ob-mock group, n = 4 in WT-mock and WT-SARS-CoV-2 groups, n = 6 in ob/ob-mock and ob/ob -SARS-CoV-2 groups). B and C, Insulin tolerance test was performed. SARS-CoV-2-infected ob/ob mice showed decreased glucose regulation response. D, Triglyceride (TG) at 5 dpi performed by biochemical analysis (**P < .01 vs ob/ob-mock group; n = 4 in WT-mock and WT-SARS-CoV-2 groups, n = 6 in ob/ob-mock and ob/ob -SARS-CoV-2 groups). E, Screenshot of microcomputed tomography (micro-CT) measurements of femurs in mice. F-J, Bone mineral density (BMD), trabecular bone volume (BV/TV), trabecular number (Tb.N), trabecular thickness (Tb.Th), and trabecular separation (Tb.Sp) at 5 dpi (n = 3 per group, *P < .05, **P < .01 vs ob/ob-mock group). Protein expression of p-PI3K, p-AKT, and p-mTOR were detected by western blot (K-N). Schematic diagram of pathogenic mechanism of target organ in DM comorbid mice (O) the pathogenesis mechanism of comorbidity associated with chronic diseases.

In this study, we generated a versatile and powerful tool to produce comorbid animal models to mimic the clinical phenotypes of SARS-CoV-2-infected patients with preexisting diseases. The replication-deficient adenovirus-mediated gene delivery to murine lungs has been applied to SARS-CoV, MERS, and SARS-CoV-2 related study. 10, 11 This strategy provides a valuable tool to understand the interplay of underlying comorbidities and COVID-19. To optimize the ectopic expression of hACE2 in murine lungs, here we tested several different virus strategies including lentivirus, replication-deficient adenovirus (Ad5), and adeno-associated virus (AAV). Among them, adenovirus mediated the highest hACE2 expression level. Here, we applied these viral vectors to other disease mouse models to produce CVD and DM comorbid mice models. We Here the widely used cardiomyopathy model and/or HF induced by ADR, and heart-specific cTnT R141W overexpression transgenic mice with typical DCM phenotypes were previously established and reported in our laboratory. 15 Moreover, direct viral invasion of cardiomyocytes, as well as a myocardial injury due to oxidative stress, may account for acute cardiac injury in COVID-19. Nevertheless, the mechanism of heart injury in COVID-19 is not clear yet. 21, [28] [29] [30] It is reported that acute viral infection produces pro-inflammatory cytokine level elevations, and infiltrating macrophage is a source of superoxide, and inflammation resulting in increased oxidative stress and evolvement of apoptotic cardiomyocytes, finally contributing to myocardial injury.

Taken together, our studies showed that the myocardial oxidative stress level increased significantly after SARS-CoV-2 infection, the mitochondrial structure and function were impaired, and the mitochondria-dependent apoptotic pathway was activated and induce myocardial apoptosis, which together with the abnormal increased inflammatory response in myocardium, jointly led to myocardial injury.

Several reports have shown that diabetes was also highly relevant with severe illness and death in COVID-19. 31 Among 1099 COVID-19 patients in China, diabetes was present in 26.9% of patients achieving severity, or death, compared with 6.1% if none of primary disease. In another report from American CDC, among 7162 COVID-19 patients, diabetes was present in 24% of non-ICU and 32% of ICU patients. 32 In our diabetic comorbid model, SARS-CoV-2 infection caused more severe histopathologic phenotypes as compared to WT-SARS-CoV-2 group or their respective mock group.

This suggests that the presence of hyperglycemia is associated with the adverse outcome of SARS-CoV-2 infection. Moreover, SARS-CoV-2 infection increased the blood glucose level both in diabetes model and WT group. This was consistent with the fact that SARS-CoV-2-infected patients exhibit increased blood glucose. 33 Previous report showed that abnormal blood glucose might impair the immune response to the viral infection and lead to secondary damages to the lungs. 34 Here, we detected that the fasting blood glucose increased both in WT-SARS-CoV-2 and ob/ob-SARS-CoV-2. The changes were more dramatic in our diabetic comorbid mice models than in WT mice. In addition, we also observed a significant increase of inflammatory cytokines, including IL-6, IL-10, TNFα, and IFNγ in the lung tissues, which was often referred to as a cytokine storm. This may further aggravate the adverse outcome during infection. We also observed reduced ITT response and this may suggest SARS-CoV-2 infection further impaired the blood glucose regulation. Maybe due to the short infection period, further damage to β-cell was not observed in both the WT-SARS-CoV-2 group and ob/ob-SARS-CoV-2 groups when compared with their mock groups (data not shown). Surprisingly, even in a short SARS-CoV-2 infection period, we detected significant decrease in bone mineral density (BMD) and this was not reported in patients yet. Our results suggest that patients with osteoporosis are likely at a high risk of adverse outcome from SARS-CoV-2 infection and need more intensive care. Our data suggested that PI3K/AKT/ mTOR pathway, but not WNT signal pathway, was involved in the DM model bone loss during SARS-CoV-2 infection.

In summary, we established a versatile strategy to build comorbid models, and our comorbid mouse models mimicked the complex pathological symptoms of COVID-19 patients with preexisting cardiovascular or diabetic diseases. They both showed impairments of immune response during SARS-CoV-2 infection, which result in damage in their related target organs. Our study provides clues to understand the characteristics of the interaction between the underlying disease and SARS-CoV-2 virus as well as possible intervention targets and directions.

Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality

Epidemiology Working Group for Ncip Epidemic Response, C.C.f.D.C., and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China

Likelihood of survival of coronavirus disease 2019

The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China

Risk factors for severity and mortality in patients with MERS-CoV: analysis of publicly available data from Saudi Arabia

A pneumonia outbreak associated with a new coronavirus of probable bat origin

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2

A mouse model of SARS-CoV-2 infection and pathogenesis

A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies

Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment

New molecular mechanism underlying Myc-mediated cytochrome P450 2E1 upregulation in apoptosis and energy metabolism in the myocardium

Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnTR141W dilated cardiomyopathy transgenic mice

Calponin1 inhibits dilated cardiomyopathy development in mice through the εPKC pathway

Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway

WIF1 causes dysfunction of heart in transgenic mice

Meox1 accelerates myocardial hypertrophic decompensation through Gata4

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Development of the obese-hyperglycaemic syndrome in mice

COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options

Knockdown of cytochrome P450 2E1 inhibits oxidative stress and apoptosis in the cTnT(R141W) dilated cardiomyopathy transgenic mice

Calponin1 inhibits dilated cardiomyopathy development in mice through the epsilonPKC pathway

Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19

Cardiovascular implications of fatal outcomes of patients with coronavirus disease

Impact of complicated myocardial injury on the clinical outcome of severe or critically ill COVID-19 patients

Cardiovascular manifestations of COVID-19 infection

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

Description and proposed management of the acute COVID-19 cardiovascular syndrome

The Science underlying COVID-19: implications for the cardiovascular system

Clinical characteristics of coronavirus disease 2019 in China

Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019 -United States

SARS-CoV-2 disease severity and diabetes: why the connection and what is to be done?

Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report

DJ-1 maintains energy and glucose homeostasis by regulating the function of brown adipose tissue

We thank Dr Yuxuan Guo 

The authors declare no competing interests.